Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00791297 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914
A Phase 2 study, sponsored by Population Council.
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
NCT00791297 is a Phase 2 study that has completed, run by Population Council. The registered enrollment target is 55 participants.
The verdict
NCT00791297, a Phase 2 study, has completed, sponsored by Population Council.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to to determine pharmacodynamic effects of a vaginal ring delivering either 1,500 or 2,500 μg of CDB-2914 per day during 6 months of treatment on: 1. follicular function and inhibition of ovulation 2. the endometrium 3. bleeding patterns; and also to assess safety including effects on the endometrium
Interventions
- DRUG CDB-2914
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2008-10 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00791297
The ClinicalTrials.gov registry entry for NCT00791297 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Population Council, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CDB-2914 is the first listed.
NCT00791297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00791297 about?
NCT00791297 is a clinical study titled "Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914". The purpose of this study is to to determine pharmacodynamic effects of a vaginal ring delivering either 1,500 or 2,500 μg of CDB-2914 per day during 6 months of treatment on: 1. follicular function and inhibition of ovulation 2. the endometrium 3. bleeding patterns; and also to assess safety inclu...
What is the current status of trial NCT00791297?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2008-10. Estimated completion is 2014-09.
What interventions are being tested in trial NCT00791297?
The interventions under investigation include: CDB-2914 (DRUG).
Who is sponsoring clinical trial NCT00791297?
This trial is sponsored by Population Council, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.